These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19262097)

  • 21. High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer.
    Tsutaho A; Hashimoto A; Hashimoto S; Hata S; Kachi S; Hirano S; Sabe H
    Cell Commun Signal; 2020 Jun; 18(1):101. PubMed ID: 32580737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin.
    Hiroi T; Someya A; Thompson W; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10672-7. PubMed ID: 16807291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins.
    Dunphy JL; Moravec R; Ly K; Lasell TK; Melancon P; Casanova JE
    Curr Biol; 2006 Feb; 16(3):315-20. PubMed ID: 16461286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of Arf6 in cancer cell invasion, metastasis and proliferation.
    Li R; Peng C; Zhang X; Wu Y; Pan S; Xiao Y
    Life Sci; 2017 Aug; 182():80-84. PubMed ID: 28625359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.
    Loskutov YV; Kozyulina PY; Kozyreva VK; Ice RJ; Jones BC; Roston TJ; Smolkin MB; Ivanov AV; Wysolmerski RB; Pugacheva EN
    Oncogene; 2015 Jul; 34(28):3662-75. PubMed ID: 25241893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells.
    Handa H; Hashimoto A; Hashimoto S; Sabe H
    Small GTPases; 2018 Sep; 9(5):420-426. PubMed ID: 27754741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for Arf6 in breast cancer invasive activities.
    Hashimoto S; Onodera Y; Hashimoto A; Tanaka M; Hamaguchi M; Yamada A; Sabe H
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6647-52. PubMed ID: 15087504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of GEP100 Improved the Growth Inhibition Effect of Erlotinib Through Modulating Mesenchymal Epithelial Transition Process in Pancreatic Cancer.
    Xie CG; Sun SL; Wei SM; Xu XM; Shao LM; Chen JM; Cai JT
    Pancreas; 2018 Jul; 47(6):732-737. PubMed ID: 29851753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subunit-selective N-Methyl-d-aspartate (NMDA) Receptor Signaling through Brefeldin A-resistant Arf Guanine Nucleotide Exchange Factors BRAG1 and BRAG2 during Synapse Maturation.
    Elagabani MN; Briševac D; Kintscher M; Pohle J; Köhr G; Schmitz D; Kornau HC
    J Biol Chem; 2016 Apr; 291(17):9105-18. PubMed ID: 26884337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.
    Hashimoto S; Hirose M; Hashimoto A; Morishige M; Yamada A; Hosaka H; Akagi K; Ogawa E; Oneyama C; Agatsuma T; Okada M; Kobayashi H; Wada H; Nakano H; Ikegami T; Nakagawa A; Sabe H
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7036-41. PubMed ID: 16636290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
    Hashimoto A; Oikawa T; Hashimoto S; Sugino H; Yoshikawa A; Otsuka Y; Handa H; Onodera Y; Nam JM; Oneyama C; Okada M; Fukuda M; Sabe H
    J Cell Biol; 2016 Apr; 213(1):81-95. PubMed ID: 27044891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
    Guerrero J; Santibañez JF; González A; Martínez J
    Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial β1 integrin recycling.
    Hongu T; Funakoshi Y; Fukuhara S; Suzuki T; Sakimoto S; Takakura N; Ema M; Takahashi S; Itoh S; Kato M; Hasegawa H; Mochizuki N; Kanaho Y
    Nat Commun; 2015 Aug; 6():7925. PubMed ID: 26239146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway.
    Tague SE; Muralidharan V; D'Souza-Schorey C
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9671-6. PubMed ID: 15210957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs.
    Yamauchi Y; Miura Y; Kanaho Y
    Adv Biol Regul; 2017 Jan; 63():115-121. PubMed ID: 27776975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation machinery of the small GTPase Arf6.
    Hongu T; Kanaho Y
    Adv Biol Regul; 2014 Jan; 54():59-66. PubMed ID: 24139303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.
    Otsuka Y; Sato H; Oikawa T; Onodera Y; Nam JM; Hashimoto A; Fukunaga K; Hatanaka KC; Hatanaka Y; Matsuno Y; Fukuda S; Sabe H
    Cell Commun Signal; 2016 Nov; 14(1):28. PubMed ID: 27871329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells.
    Uehara S; Saito K; Asami H; Ohta Y
    Anticancer Res; 2017 Sep; 37(9):4837-4844. PubMed ID: 28870903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fbx8 makes Arf6 refractory to function via ubiquitination.
    Yano H; Kobayashi I; Onodera Y; Luton F; Franco M; Mazaki Y; Hashimoto S; Iwai K; Ronai Z; Sabe H
    Mol Biol Cell; 2008 Mar; 19(3):822-32. PubMed ID: 18094045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
    Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.